
John Eric Hug
Examiner (ID: 208, Phone: (571)272-1192 , Office: P/1741 )
| Most Active Art Unit | 1731 |
| Art Unit(s) | 1741, 1791, 1731, 1748 |
| Total Applications | 1588 |
| Issued Applications | 1319 |
| Pending Applications | 41 |
| Abandoned Applications | 236 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9875530
[patent_doc_number] => 08962796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Modified variant Bowman Birk protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/756337
[patent_app_country] => US
[patent_app_date] => 2013-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 32
[patent_no_of_words] => 118693
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 292
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13756337
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/756337 | Modified variant Bowman Birk protease inhibitors | Jan 30, 2013 | Issued |
Array
(
[id] => 8892209
[patent_doc_number] => 20130165393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'PHOSPHOLIPID AND PROTEIN TABLETS'
[patent_app_type] => utility
[patent_app_number] => 13/748013
[patent_app_country] => US
[patent_app_date] => 2013-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27682
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13748013
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/748013 | PHOSPHOLIPID AND PROTEIN TABLETS | Jan 22, 2013 | Abandoned |
Array
(
[id] => 9793536
[patent_doc_number] => 20150005480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'Affinity Tag System'
[patent_app_type] => utility
[patent_app_number] => 14/369331
[patent_app_country] => US
[patent_app_date] => 2013-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10748
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369331
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/369331 | Affinity tag system | Jan 6, 2013 | Issued |
Array
(
[id] => 8822459
[patent_doc_number] => 20130123504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'PHARMACOLOGICALLY ACTIVE COMPOUNDS CONTAINING SULFUR'
[patent_app_type] => utility
[patent_app_number] => 13/734270
[patent_app_country] => US
[patent_app_date] => 2013-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8166
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13734270
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/734270 | Pharmacologically active compounds containing sulfur | Jan 3, 2013 | Issued |
Array
(
[id] => 10968105
[patent_doc_number] => 20140371139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE'
[patent_app_type] => utility
[patent_app_number] => 14/365841
[patent_app_country] => US
[patent_app_date] => 2012-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3389
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14365841
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/365841 | Preparations containing amorphous emodepside | Dec 17, 2012 | Issued |
Array
(
[id] => 9204917
[patent_doc_number] => 20140004094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/713019
[patent_app_country] => US
[patent_app_date] => 2012-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 94
[patent_figures_cnt] => 94
[patent_no_of_words] => 42683
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13713019
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/713019 | COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES | Dec 12, 2012 | Abandoned |
Array
(
[id] => 9538289
[patent_doc_number] => 20140162937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'POLYMYXIN DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/709657
[patent_app_country] => US
[patent_app_date] => 2012-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26182
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13709657
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/709657 | Polymyxin derivatives and uses thereof | Dec 9, 2012 | Issued |
Array
(
[id] => 8865618
[patent_doc_number] => 20130149321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'CANDIDATES AGAINST INFECTION'
[patent_app_type] => utility
[patent_app_number] => 13/685466
[patent_app_country] => US
[patent_app_date] => 2012-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21686
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13685466
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/685466 | CANDIDATES AGAINST INFECTION | Nov 25, 2012 | Abandoned |
Array
(
[id] => 8733715
[patent_doc_number] => 20130079284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'TREATMENT OF T-CELL MEDIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/679599
[patent_app_country] => US
[patent_app_date] => 2012-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9987
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13679599
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/679599 | TREATMENT OF T-CELL MEDIATED DISEASES | Nov 15, 2012 | Abandoned |
Array
(
[id] => 8720231
[patent_doc_number] => 20130071448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'TREATMENT OF T-CELL MEDIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/676966
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9993
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676966
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/676966 | Treatment of T-cell mediated diseases | Nov 13, 2012 | Issued |
Array
(
[id] => 9882543
[patent_doc_number] => 08969308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => 'Treatment of T-cell mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 13/676932
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10017
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/676932 | Treatment of T-cell mediated diseases | Nov 13, 2012 | Issued |
Array
(
[id] => 8721467
[patent_doc_number] => 20130072684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'TREATMENT OF T-CELL MEDIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/677007
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9992
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13677007
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/677007 | Treatment of T-cell mediated diseases | Nov 13, 2012 | Issued |
Array
(
[id] => 8982082
[patent_doc_number] => 08513196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Treatment of T-cell mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 13/676984
[patent_app_country] => US
[patent_app_date] => 2012-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10018
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676984
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/676984 | Treatment of T-cell mediated diseases | Nov 13, 2012 | Issued |
Array
(
[id] => 9162261
[patent_doc_number] => 20130310538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 13/674285
[patent_app_country] => US
[patent_app_date] => 2012-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7514
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13674285
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/674285 | METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES | Nov 11, 2012 | Abandoned |
Array
(
[id] => 8884748
[patent_doc_number] => 20130157932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'NGAL AND URINARY TRACT INFECTION'
[patent_app_type] => utility
[patent_app_number] => 13/671533
[patent_app_country] => US
[patent_app_date] => 2012-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 25711
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13671533
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/671533 | NGAL AND URINARY TRACT INFECTION | Nov 6, 2012 | Abandoned |
Array
(
[id] => 9786259
[patent_doc_number] => 20140303080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'N-ACYLDIPEPTIDE DERIVATIVES AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 14/354711
[patent_app_country] => US
[patent_app_date] => 2012-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21081
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354711
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354711 | N-acyldipeptide derivatives and their uses | Oct 30, 2012 | Issued |
Array
(
[id] => 8822141
[patent_doc_number] => 20130123186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS'
[patent_app_type] => utility
[patent_app_number] => 13/664168
[patent_app_country] => US
[patent_app_date] => 2012-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17343
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13664168
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/664168 | NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS | Oct 29, 2012 | Abandoned |
Array
(
[id] => 8671484
[patent_doc_number] => 20130046023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING GLUR2-LACKING AMPAR ANTAGONIST FOR PREVENTING OR TREATING PSYCHIATRIC ILLNESSES'
[patent_app_type] => utility
[patent_app_number] => 13/658899
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2968
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13658899
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/658899 | Pharmaceutical composition containing GLUR2-lacking AMPAR antagonist for preventing or treating psychiatric illnesses | Oct 23, 2012 | Issued |
Array
(
[id] => 8858653
[patent_doc_number] => 08461188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/655704
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15135
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655704
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/655704 | Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use | Oct 18, 2012 | Issued |
Array
(
[id] => 8939414
[patent_doc_number] => 20130189211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'Cosmetic Compositions'
[patent_app_type] => utility
[patent_app_number] => 13/655268
[patent_app_country] => US
[patent_app_date] => 2012-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6405
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655268
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/655268 | Cosmetic Compositions | Oct 17, 2012 | Abandoned |